HOXA1 and neoplasm: miR-100-5p inhibits cell proliferation, migration, and invasion, as well as signaling pathways such as Wnt/β-catenin, particularly in non-small cell lung cancer (NSCLC), where it targets HOXA1 to suppress tumor progression and epithelial-mesenchymal transition (EMT) [23,37,41–47].